Company news

Connect Biopharma Holdings Limited news in 2021

Connect Biopharma Holdings Limited's news releases, calls and decks from 2021, newest first.

View company

Connect Biopharma Expands Executive Leadership Team with Hire of Chief Financial Officer

November 21, 2021

Connect Biopharma Completes Enrollment of CBP-307 Global Phase 2 Clinical Trial in Moderate-to-Severe Ulcerative Colitis

November 18, 2021

Connect Biopharma Reports Positive Top-Line Results from the Global Phase 2 Clinical Trial of CBP-201 in Patients with Moderate-to-Severe Atopic Dermatitis

November 17, 2021

Connect Biopharma Announces First Subject Dosed in Phase 2 Trial Evaluating CBP-201 in Adult Patients with Chronic Rhinosinusitis with Nasal Polyps

September 7, 2021

Connect Biopharma Announces First Patient Dosed in China Pivotal Trial Evaluating CBP-201 in Adults with Moderate-to-Severe Atopic Dermatitis

September 1, 2021

Connect Biopharma Provides Business Update and Reports First Half 2021 Financial Results

August 30, 2021

Connect Biopharma Hires General Counsel & Chief Compliance Officer and Appoints a New Board Member

August 22, 2021

Connect Biopharma Announces First Subject Dosed in Phase I Trial Evaluating Safety, Tolerability and Pharmacokinetic Profile of CBP-174 in Healthy Adult Subjects

May 24, 2021

Connect Biopharma Announces First Patient Dosed in Phase 2 Trial Evaluating CBP-201 in Adults with Moderate-to-Severe Persistent Asthma

May 11, 2021

Connect Biopharma Completes Enrollment of CBP-201 Global Phase 2 Clinical Trial in Moderate-to-Severe Atopic Dermatitis

April 7, 2021

Connect Biopharma Holdings Limited Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares

March 22, 2021

Calls in 2021

Decks in 2021